Skip to content

Prospective randomized study of the usefulness of two- or three-dimensional laparoscopy for laparoscopic gastrectomy in gastric cancer patients

Prospective randomized controlled study of 2-dimensional versus 3-dimensional laparoscopic gastrectomy for gastric adenocarcinoma

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CRIS
Registry ID
KCT0003862
Enrollment
248
Registered
2019-04-29
Start date
2016-10-20
Completion date
Unknown
Last updated
2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : Patients with histologically confirmed gastric adenocarcinoma and =cT4a tumor were randomly assigned to the 2D or 3D group.

Sponsors

Seoul National University Bundang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Pathologically confirmed gastric adenocarcinoma patients (2) Patients aged between 20 years and 80 years (3) Patients whose adenocarcinoma did not penetrate adjacent organ (4) Patients whose cancer could be radially resected. (5) Patients who agreed to participate in the study after hearing the outline of the study(If family or guardian does not want to notify the patient, get consent from family or guardian). .

Exclusion criteria

Exclusion criteria: (1) Patients who has abdominal operation history including gastrectomy (2) Patients who need adjacent organ resection. Patients who need splenectomy for lymphadenectomy are also excluded. (3) Patients who are currently being treated with systemic inflammatory disease or have a history of treatment.

Design outcomes

Primary

MeasureTime frame
Operation time

Secondary

MeasureTime frame
Estimated blood loss;Amount of blood transfusion;Number of retrieved lymph nodes;Postoperative mortality;Open conversion rate

Countries

Korea, Republic of

Contacts

Public ContactYoungsuk Park

Seoul National University Bundang Hospital

youngsukmd@gmail.com+82-31-787-7099

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026